ECSP066916A - Vacuna contra estreptococo agalactiae - Google Patents

Vacuna contra estreptococo agalactiae

Info

Publication number
ECSP066916A
ECSP066916A EC2006006916A ECSP066916A ECSP066916A EC SP066916 A ECSP066916 A EC SP066916A EC 2006006916 A EC2006006916 A EC 2006006916A EC SP066916 A ECSP066916 A EC SP066916A EC SP066916 A ECSP066916 A EC SP066916A
Authority
EC
Ecuador
Prior art keywords
estreptococo
agalactiae
vaccine against
agalacitae
hemolytic
Prior art date
Application number
EC2006006916A
Other languages
English (en)
Inventor
Joyce J Evans
Phillip H Klesius
Craig A Shoemaker
Original Assignee
Us Of America As Repr By Secretary Of Agriculture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Of America As Repr By Secretary Of Agriculture filed Critical Us Of America As Repr By Secretary Of Agriculture
Publication of ECSP066916A publication Critical patent/ECSP066916A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Una composición preparada a partir de células muertas intactas de b-estreptococos agalacitae hemolítico y un extracto concentrado de un cultivo de b-estreptococos agalacitae hemolítico, como efectivas vacunas en contra de la infección en peces producida por el mismo u otros virulentos extraños,estreptococos agalatiae,
EC2006006916A 2004-03-18 2006-10-10 Vacuna contra estreptococo agalactiae ECSP066916A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/807,575 US7204993B2 (en) 2004-03-18 2004-03-18 Streptococcus agalactiae vaccine

Publications (1)

Publication Number Publication Date
ECSP066916A true ECSP066916A (es) 2007-01-26

Family

ID=34986574

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006916A ECSP066916A (es) 2004-03-18 2006-10-10 Vacuna contra estreptococo agalactiae

Country Status (9)

Country Link
US (1) US7204993B2 (es)
EP (1) EP1732597A4 (es)
JP (1) JP2007532485A (es)
CN (1) CN101068566A (es)
CA (1) CA2559969A1 (es)
CR (1) CR8638A (es)
EC (1) ECSP066916A (es)
IL (1) IL178078A0 (es)
WO (1) WO2005089447A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7204993B2 (en) * 2004-03-18 2007-04-17 The United States Of America As Represented By The Secretary Of Agriculture Streptococcus agalactiae vaccine
JP5567244B2 (ja) * 2006-06-06 2014-08-06 共立製薬株式会社 魚類ストレプトコッカス・ディスガラクティエを抗原とする不活化ワクチン
MX2008016248A (es) * 2006-07-06 2009-03-05 Intervet Int Bv Vacuna combinada estreptococica.
US9078458B2 (en) * 2009-03-06 2015-07-14 Kenneth William Gregg Composition for controlling fish
WO2011044576A2 (en) * 2009-10-09 2011-04-14 Children's Medical Center Corporation Selectively disrupted whole-cell vaccine
WO2011048041A1 (en) 2009-10-19 2011-04-28 Intervet International B.V. Streptococcal combi-vaccine
CN101890159B (zh) * 2010-06-23 2012-07-25 广西壮族自治区水产研究所 罗非鱼二联链球菌灭活疫苗的制备方法
JP5962892B2 (ja) * 2011-02-18 2016-08-03 共立製薬株式会社 海面養殖魚用ワクチン製剤、並びに感染症予防方法
CN102847146B (zh) * 2011-09-15 2013-12-11 通威股份有限公司 一种预防罗非鱼链球菌病的疫苗
CN102676683B (zh) * 2012-05-31 2014-02-26 广西壮族自治区水产研究所 一种鱼类无乳链球菌疫苗候选菌株筛选方法
WO2015121863A1 (en) 2014-02-12 2015-08-20 Transalgae Israel Ltd. Algal based edible vaccines
IL230970A0 (en) 2014-02-13 2014-09-30 Univ Ramot Tilapia virus vaccines
CN104152368B (zh) * 2014-03-11 2016-09-28 广西壮族自治区水产科学研究院 罗非鱼源无乳链球菌弱毒株及应用
CN104906568A (zh) * 2015-04-09 2015-09-16 广西壮族自治区水产科学研究院 一种罗非鱼无乳链球菌病口服弱毒冻干疫苗
CN105334324B (zh) * 2015-11-06 2017-06-27 通威股份有限公司 无乳链球菌单克隆抗体及其制备方法和用途
CN112386683A (zh) * 2020-11-06 2021-02-23 中国水产科学研究院淡水渔业研究中心 罗非鱼源无乳链球菌胞外产物二价灭活疫苗及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4324887A (en) * 1978-08-16 1982-04-13 President And Fellows Of Harvard College Type II group B Streptococci polysaccharide
US4207414A (en) * 1978-08-16 1980-06-10 President And Fellows Of Harvard College Polysaccharide antigens
US4425330A (en) * 1981-05-20 1984-01-10 Cornell Research Foundation, Inc. Bovine mastitis vaccine and method for detecting efficacy thereof
US5780448A (en) * 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish
JP2001161355A (ja) * 1999-11-25 2001-06-19 Natl Sci Council ハタ科チャイロマルハタから得られる不死の細胞株およびその応用
US6379677B1 (en) 2000-02-25 2002-04-30 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Streptococcus iniae vaccine
JP2005516897A (ja) * 2001-11-07 2005-06-09 イネックス ファーマシューティカルズ コーポレイション 改善された粘膜のワクチン及びその使用方法
US7204993B2 (en) * 2004-03-18 2007-04-17 The United States Of America As Represented By The Secretary Of Agriculture Streptococcus agalactiae vaccine

Also Published As

Publication number Publication date
CN101068566A (zh) 2007-11-07
US7204993B2 (en) 2007-04-17
EP1732597A2 (en) 2006-12-20
IL178078A0 (en) 2008-03-20
WO2005089447A3 (en) 2007-04-12
CA2559969A1 (en) 2005-09-29
EP1732597A4 (en) 2008-02-27
WO2005089447A2 (en) 2005-09-29
CR8638A (es) 2007-05-30
JP2007532485A (ja) 2007-11-15
US20050208077A1 (en) 2005-09-22

Similar Documents

Publication Publication Date Title
ECSP066916A (es) Vacuna contra estreptococo agalactiae
AR071917A1 (es) Vacunas contra la coccidiosis
EP2468296A3 (en) Yeast-based vaccine for inducing an immune response
CO6880050A2 (es) Composiciones y metodos para controlar la fusariosis
MY165831A (en) Methods of reducing virucidal activity in pcv-2 compositions and pcv-2 compositions with a improved immunogenicity
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
ECSP13012473A (es) Forma de dosificación resistente a alteración que comprende un polímero aniónico
WO2008039874A3 (en) Cancer stem cell antigen vaccines and methods
AR077314A1 (es) Produccion de titulos elevados de poliovirus para la produccion de vacunas
UA99659C2 (uk) Мультивалентна вакцина з нативних везикул зовнішньої мембрани менінгококів, способи її застосування
AR081809A1 (es) Composiciones farmaceuticas que comprenden un polipeptido que comprende al menos un motivo cxxc y antigenos heterologos y usos de las mismas
CL2011001993A1 (es) Composicion inmunogenica que comprende al menos un antigeno del virus del dengue inactivado y un adyuvante sin aluminio; metodo de produccion; y su uso para prevenir, mejorar o tratar una enfermedad productiva por el virus del dengue en un sujeto.
CO6470893A2 (es) Agente y método de control para podredumbre blanda
BRPI0721892A2 (pt) Composição de vacina, inalador, célula, métodos para vacinar um animal contra uma infecção bacteriana, para preparar uma linhagem de célula de hibridoma, e para preparar uma vacina para um patógeno bacteriano, usos de uma composição, de soros humanos, e de um anticorpo humano, linhagem de célula de hibridoma, anticorpo, fragmento de ligação ativo, soro, processo para a produção de uma vacina, e, cultura de célula bacteriana
EA201300132A1 (ru) Фармацевтическая композиция и методы лечения и профилактики заболеваний, вызванных вич или ассоциированных с вич
DK201300292A (en) Fish vaccine
CO6280408A2 (es) Vacuna de virus de la lengua azul y composiciones inmunogenicas procedimientos de uso y procedimeintos de la produccuion de la misma
AR068144A1 (es) Administracion subcutanea de alfa-galactosidasa a
ECSP15022084A (es) Composición que comprende un agente de control biológico y un fungicida
MX344544B (es) Vacuna para paludismo en etapa sanguinea.
DE60336588D1 (de) Verbesserte anthraximpfstoffe und abgabeverfahren
PE20211648A1 (es) Composicion de vacuna combinada que comprende dosis reducidas del virus inactivado de la polio y metodo de preparacion de la misma
NZ603854A (en) West nile virus vaccine
CR10116A (es) Enzimas para estres inmunólogico reducido
AR060182A1 (es) Polisacaridos capsulares tipo 5 y tipo 8 de cepas s. aureus de sobreproduccion